Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B07c75d2f986bf22bc32f5ac154a41cb9> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B07c75d2f986bf22bc32f5ac154a41cb9 NCIT_P378 "NCI" @default.
- B07c75d2f986bf22bc32f5ac154a41cb9 type Axiom @default.
- B07c75d2f986bf22bc32f5ac154a41cb9 annotatedProperty IAO_0000115 @default.
- B07c75d2f986bf22bc32f5ac154a41cb9 annotatedSource NCIT_C160003 @default.
- B07c75d2f986bf22bc32f5ac154a41cb9 annotatedTarget "A regimen consisting of brentuximab vedotin that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL), Hodgkin lymphoma (HL), T-cell lymphoma, primary cutaneous CD30+ T-cell lymphoproliferative disorders, and mycosis fungoides/Sezary syndrome." @default.